Finerenone for Patients With CKD and Type 2 Diabetes

Finerenone reduced the risks of chronic kidney disease (CKD) progression and cardiovascular events among patients with CKD and type 2 diabetes in an international phase 3 trial.
Source: JAMA - Category: General Medicine Source Type: research